-
Novobiocin Sodium: DNA Replication Workflows
2026-09-16
Novobiocin Sodium provides a practical way to separate bacterial DNA replication arrest from genomic DNA degradation while linking replication status to membrane growth and vacuole formation. This workflow translates a time-resolved Enterococcus faecalis protoplast study into reproducible microscopy, qPCR, washout, and antibiotic-resistance experiments.
-
Oridonin Protects Bone Through MAPK/NF-κB and BMP-2
2026-09-15
The reference study identifies oridonin as a dual-action candidate that suppresses thioacetamide-induced osteoclastogenesis while restoring osteoblast differentiation. Its mechanistic contribution is the connection of MAPK/NF-κB signaling in bone resorption with BMP-2/RUNX2 signaling in bone formation, providing a framework for studying therapies that address both sides of skeletal remodeling.
-
Telatinib: Mapping VEGF Signaling in TNBC
2026-09-15
Telatinib (BAY 57-9352) offers a multitarget framework for studying angiogenesis, invasion, and tumor-cell signaling in triple-negative breast cancer. This thought-leadership guide connects receptor-level pharmacology with phenotype-driven validation and translational decision-making.
-
Tetramethylrhodamine ethyl ester perchlorate assays
2026-09-14
Use TMRE to convert mitochondrial membrane-potential changes into actionable live-cell imaging and flow-cytometry data. This guide connects practical staining workflows with a new caspase-3/NDUFS1 mechanism implicated in trichothecene-induced liver injury, while highlighting controls and troubleshooting steps that prevent overinterpretation.
-
DiscoveryProbe™ Immunology Library: Assay Strategy
2026-09-14
The DiscoveryProbe Immunology/Inflammation Compound Library supports a decision-focused strategy for target validation, immune pathway profiling, and phenotypic screening. Learn how to combine its chemically diverse 295-compound set with multiplex PBMC measurements to distinguish genuine immunomodulation from cytotoxicity and assay artifacts.
-
TMEM16F Lipid Scrambling Shapes Ferroptosis Immunity
2026-09-13
Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as a late-stage suppressor of ferroptosis. Loss or inhibition of this process promotes membrane collapse, danger-signal release, tumor control, and stronger responses to PD-1 blockade, highlighting membrane mechanics as an immunologically relevant layer of ferroptosis biology.
-
Patient-Derived Gastric Cancer Assembloid Model
2026-09-12
Shapira-Netanelov and colleagues developed gastric cancer assembloids that combine patient-matched tumor organoids with tumor-derived stromal subpopulations. The model captures microenvironment-dependent gene expression and drug-response differences that are not apparent in organoid monocultures, strengthening its value for personalized cancer biology research.
-
Ibotenic Acid Workflows for Neurodegeneration Models
2026-09-11
Build more interpretable excitotoxicity and circuit-mapping experiments with Ibotenic acid, an NMDA receptor agonist whose dual glutamatergic activity supports disease modeling. A time-resolved workflow separates early neuronal activation from later injury, while practical solubility, control, and troubleshooting guidance improves reproducibility.
-
DAPI Nuclear Stain Solution: Practical Guide
2026-09-11
DAPI (4',6-Diamino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a ready-to-use fluorescent DNA binding dye for nuclear visualization, endpoint cell viability assessment, and apoptosis-related nuclear evaluation. Its weak cell permeability makes it more appropriate for fixed or membrane-compromised samples than for routine staining of intact live cells.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-09-10
The 2024 Development study identifies SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary cilium integrity, and brain development. Using a mouse model and SMPD4-deficient human induced pluripotent stem cells, the authors connect ceramide deficiency with cerebellar hypoplasia, neural progenitor loss, and shortened cilia, while showing that exogenous ceramide can rescue the ciliary phenotype.
-
KR-12 Design, Mechanisms, and Translational Potential
2026-09-10
The 2024 review on KR-12 presents this LL-37-derived fragment as a compact platform for membrane-targeting antimicrobial, antibiofilm, endotoxin-neutralizing, and immune-regulatory research. Its central innovation is the systematic use of peptide engineering, formulation, and biomaterial immobilization to address the activity, stability, and delivery limitations of native KR-12.
-
BFH772 (VEGFR2 inhibitor): Workflow Guide
2026-09-09
BFH772 is a selective small-molecule VEGFR2 inhibitor for biochemical, cellular, and tumor angiogenesis research where organic-solvent compatibility and target-focused pathway modulation are required. It should not be selected for water-soluble assay systems or interpreted as a broad-spectrum kinase inhibitor without an appropriate counter-screen.
-
High-Throughput Discovery of M. tuberculosis DHFR Inhibitors
2026-09-09
The ACS Chemical Biology study linked whole-cell antibacterial phenotypes with broad biophysical target-binding profiles through machine learning. Its retrospective validation and prospective discovery of nanomolar Mycobacterium tuberculosis dihydrofolate reductase inhibitors show how integrated screening can improve mechanism-of-action assignment and prioritize actionable chemical matter.
-
Ruthenium Red: A Strategic Lens on Ca2+ Signaling
2026-09-08
Ruthenium Red provides a practical way to interrogate calcium transport in mechanotransduction, cytoskeleton-dependent autophagy, mitochondrial calcium uptake inhibition, and neurogenic inflammation research. This thought-leadership guide connects product-level mechanism with translational experimental strategy, controls, limitations, and future-facing validation workflows.
-
4μ8C Workflows for IRE1α and ER Stress
2026-09-08
4μ8C enables selective interrogation of IRE1α RNase outputs without treating ER stress as a proxy for cell death. This guide translates the compound into practical workflows for hypoxia studies, cancer research, and exploratory analysis of ER–innate immune pathway interactions.